Inactive Instrument

Metabolix, Inc. Stock Nasdaq

Equities

US5910188094

Biotechnology & Medical Research

Sales 2024 * 2.25M Sales 2025 * 4M Capitalization 3.68M
Net income 2024 * -11M Net income 2025 * -13M EV / Sales 2024 * 1.64 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.92 x
P/E ratio 2024 *
-0.32 x
P/E ratio 2025 *
-0.28 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : Yield10 Bioscience, Inc., Q4 2023 Earnings Call, Apr 01, 2024
Yield10 Bioscience, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Yield10 Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Yield10 Bioscience, Inc. Announces the Plant Biosafety Office of the Canadian Food Inspection Agency Clear Genome-edited E3902 Camelina for Planting in Canada CI
North American Morning Briefing : Markets Steady -2- DJ
Top Midday Gainers MT
Yield10 Bioscience, Inc. Grants Global License to VISION Bioenergy Oilseeds, LLC for Herbicide Tolerant Camelina Cultivated for Production of Biofuel Feedstock CI
North American Morning Briefing : Stock Futures -2- DJ
Lake Street Downgrades Yield10 Bioscience to Hold From Buy, Cuts Price Target to $0.50 From $3 MT
Wall Street Set to Open Flat Wednesday; Jobless Claims Fall More Than Expected MT
US Futures Marginally Lower Ahead of Jobless Claims, Wholesale Trade Data MT
Yield10 Bioscience, Inc. Provides an Update on Its Omega-3 Camelina Program CI
Yield10 Bioscience, Inc. Files Request for Regulatory Status Review with USDA-APHIS for Camelina Designed to Produce the EPA and DHA Components of Omega-3 Oil CI
Transcript : Yield10 Bioscience, Inc., Q3 2023 Earnings Call, Nov 14, 2023
Yield10 Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
More news
Managers TitleAgeSince
Founder 66 92-05-31
Director of Finance/CFO 68 07-12-31
Chief Tech/Sci/R&D Officer 56 96-12-31
Members of the board TitleAgeSince
Chairman 67 06-09-30
Director/Board Member 61 17-03-01
Founder 66 92-05-31
More insiders
Yield10 Bioscience, Inc., formerly Metabolix, Inc., is an agricultural bioscience company. The Company is focused on developing disruptive technologies for step-change improvements in crop yield for food and feed crops to enhance global food security. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism to direct more carbon to seed production, the Company is advancing several yield traits it has developed in crops, such as Camelina, canola, soybean and corn. The Company concentrates on technologies that enables it to improve carbon dioxide fixation efficiency in photosynthesis and its direction to and conversion into plant matter. The Company has an additional agricultural science facility with greenhouses in Saskatoon, Saskatchewan, Canada.
More about the company